205 related articles for article (PubMed ID: 37669874)
1. Manipulating PTPRD function with ectodomain antibodies.
Qian Z; Song D; Ipsaro JJ; Bautista C; Joshua-Tor L; Yeh JT; Tonks NK
Genes Dev; 2023 Aug; 37(15-16):743-759. PubMed ID: 37669874
[TBL] [Abstract][Full Text] [Related]
2. Advancing therapeutics using antibody-induced dimerization of receptor tyrosine phosphatases.
Tremblay ML
Genes Dev; 2023 Aug; 37(15-16):678-680. PubMed ID: 37673461
[TBL] [Abstract][Full Text] [Related]
3. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation.
Zhang F; Wang B; Qin T; Wang L; Zhang Q; Lu Y; Song B; Yu X; Li L
Mol Cell Biochem; 2020 Oct; 473(1-2):1-13. PubMed ID: 32602014
[TBL] [Abstract][Full Text] [Related]
4. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
Veeriah S; Brennan C; Meng S; Singh B; Fagin JA; Solit DB; Paty PB; Rohle D; Vivanco I; Chmielecki J; Pao W; Ladanyi M; Gerald WL; Liau L; Cloughesy TC; Mischel PS; Sander C; Taylor B; Schultz N; Major J; Heguy A; Fang F; Mellinghoff IK; Chan TA
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9435-40. PubMed ID: 19478061
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated point mutations within the extracellular domain of PTPRD affect protein stability and HSPG interaction.
Matsui Y; Imai A; Izumi H; Yasumura M; Makino T; Shimizu T; Sato M; Mori H; Yoshida T
FASEB J; 2024 Apr; 38(7):e23609. PubMed ID: 38593345
[TBL] [Abstract][Full Text] [Related]
6. Loss of Tyrosine Phosphatase Delta Promotes Gastric Cancer Progression via Signal Transducer and Activator of Transcription 3 Pathways.
Wu L; Gao L; Kong D; Xue H
Dig Dis Sci; 2019 Nov; 64(11):3164-3172. PubMed ID: 31041642
[TBL] [Abstract][Full Text] [Related]
7. Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma.
Walia V; Prickett TD; Kim JS; Gartner JJ; Lin JC; Zhou M; Rosenberg SA; Elble RC; Solomon DA; Waldman T; Samuels Y
Hum Mutat; 2014 Nov; 35(11):1301-10. PubMed ID: 25113440
[TBL] [Abstract][Full Text] [Related]
8. PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin.
Bae WJ; Ahn JM; Byeon HE; Kim S; Lee D
J Exp Clin Cancer Res; 2019 Dec; 38(1):484. PubMed ID: 31805999
[TBL] [Abstract][Full Text] [Related]
9. Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases.
Blanchetot C; Tertoolen LG; Overvoorde J; den Hertog J
J Biol Chem; 2002 Dec; 277(49):47263-9. PubMed ID: 12376545
[TBL] [Abstract][Full Text] [Related]
10. Redox regulation of dimerization of the receptor protein-tyrosine phosphatases RPTPalpha, LAR, RPTPmu and CD45.
Groen A; Overvoorde J; van der Wijk T; den Hertog J
FEBS J; 2008 May; 275(10):2597-604. PubMed ID: 18422654
[TBL] [Abstract][Full Text] [Related]
11. Metastasis suppressor 1 interacts with protein tyrosine phosphatase receptor-δ to regulate adipogenesis.
Chen M; Dong Y; Tian L; Zhou J; Zhu E; Yuan H; Li X; Wang B
FASEB J; 2023 Apr; 37(4):e22857. PubMed ID: 36906292
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene.
Meehan M; Parthasarathi L; Moran N; Jefferies CA; Foley N; Lazzari E; Murphy D; Ryan J; Ortiz B; Fabius AW; Chan TA; Stallings RL
Mol Cancer; 2012 Feb; 11():6. PubMed ID: 22305495
[TBL] [Abstract][Full Text] [Related]
13. Receptor protein tyrosine phosphatases are novel components of a polycystin complex.
Boucher CA; Ward HH; Case RL; Thurston KS; Li X; Needham A; Romero E; Hyink D; Qamar S; Roitbak T; Powell S; Ward C; Wilson PD; Wandinger-Ness A; Sandford RN
Biochim Biophys Acta; 2011 Oct; 1812(10):1225-38. PubMed ID: 21126580
[TBL] [Abstract][Full Text] [Related]
14. Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases.
Chagnon MJ; Uetani N; Tremblay ML
Biochem Cell Biol; 2004 Dec; 82(6):664-75. PubMed ID: 15674434
[TBL] [Abstract][Full Text] [Related]
15. The Protein Tyrosine Phosphatase Receptor Delta Regulates Developmental Neurogenesis.
Tomita H; Cornejo F; Aranda-Pino B; Woodard CL; Rioseco CC; Neel BG; Alvarez AR; Kaplan DR; Miller FD; Cancino GI
Cell Rep; 2020 Jan; 30(1):215-228.e5. PubMed ID: 31914388
[TBL] [Abstract][Full Text] [Related]
16. Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications.
Jiang Y; Janku F; Subbiah V; Angelo LS; Naing A; Anderson PM; Herzog CE; Fu S; Benjamin RS; Kurzrock R
Oncotarget; 2013 Jun; 4(6):884-9. PubMed ID: 23800680
[TBL] [Abstract][Full Text] [Related]
17. Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.
Uhl GR; Martinez MJ; Paik P; Sulima A; Bi GH; Iyer MR; Gardner E; Rice KC; Xi ZX
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11597-11602. PubMed ID: 30348770
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC.
Sun Y; Duan J; Fang W; Wang Z; Du X; Wang X; Li C; Cai S; Zhao J; Li S; Zhang L; Bai H; Wang J
BMC Med; 2021 Oct; 19(1):239. PubMed ID: 34615542
[TBL] [Abstract][Full Text] [Related]
19. Redox-regulated rotational coupling of receptor protein-tyrosine phosphatase alpha dimers.
van der Wijk T; Blanchetot C; Overvoorde J; den Hertog J
J Biol Chem; 2003 Apr; 278(16):13968-74. PubMed ID: 12582170
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies of PTPRD phosphatase inhibitors identify a 7-cyclopentymethoxy illudalic acid analog candidate for development.
Henderson IM; Zeng F; Bhuiyan NH; Luo D; Martinez M; Smoake J; Bi F; Perera C; Johnson D; Prisinzano TE; Wang W; Uhl GR
Biochem Pharmacol; 2022 Jan; 195():114868. PubMed ID: 34863978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
